Each year, Frost & Sullivan presents this award to the company that has introduced rightfully innovative products, practices, or ideas to the specified industry or segment. The winner's groundbreaking contributions to healthcare must make it possible to envision a new grade of forethought in the diagnosis, discourse, and management of disease, leading to better outcomes and quality of life for patients. In accession, the company's innovative efforts may too lead to improvements in the tools that clinicians, diagnosticians, researchers, and health care administrators have at their disposal to improve lineament and efficiency in planning of health care services.
"After conducting exhaustive research in the customized care market place, Frost & Sullivan is pleased to recognize ConforMIS as the worthy recipient of the 2008 Medical Device Healthcare Innovation Award," Frost & Sullivan Research Analyst Archana Swathy aforesaid. "Their advanced technology creates implants that precisely fit each individual patient, as opposed to the criterion one-size-fits-all plan of attack. ConforMIS offers treatment options where none were antecedently available. Not only does this advancement allow for the treatment of a broader range of patients, it besides creates a less invasive surgical procedure."
In recognizing ConforMIS, Frost & Sullivan noted that the company's commitment to improving patients' quality of life and helping surgeons serve patients more efficaciously were key factors in the survival of the fittest process. "We are honored to be recognized for this awarding, which gave weight to both our technology platforms and our personalized approach to aesculapian care," aforesaid Philipp Lang, Chairman and CEO of ConforMIS. "Frost & Sullivan has a great reputation for inquiry so it means fifty-fifty more that their analysts selected us from the broad compass of modern medical device companies."
Noteworthy milestones for ConforMIS in 2008 let included the commercial set in motion of its iUni� uni-compartmental resurfacing system and the iDuo� bi-compartmental resurfacing system. These patient-specific, partial knee resurfacing systems are examples of the innovative, minimally invasive solutions that the company has been able to land to market place through their patient-specific attack. In May, ConforMIS was also accepted as one of the most forward-looking technology companies by the selection committee of the Red Herring 100 Award.
About ConforMIS, Inc.
ConforMIS, Inc. is a privately held caller that develops and commercializes medical devices for the treatment of osteoarthritis and joint indemnification. The Company's novel and scaleable 'image-to-implant' process is comprised of two related to technology platforms. iFit� Technology enables the creation of conforming, patient-specific implants that are precisely sized and shaped to match the 3D topography of the patient's material body. iJig� Instrumentation enables the creation of disposable, easy-to-use instrumentation that simplifies the surgical process and improves reproducibility.
Both platforms are supported by proprietary, intellectual property consisting of more than than great hundred patents and pending patent applications that span tomography software, image processing, implant design, surgical techniques and instrumentation.
To date, ConforMIS has developed a comprehensive line of minimally traumatic, bone and cartilage-preserving knee implants and instrumentation designed to address all stages of degenerative arthritis. Each of these devices has been cleared by the US Food and Drug Administration for merchandising in the U.S.
ConforMIS, Inc.
More information
- Antihypertensive Treatment On Cognitive Functions In Alzheimer’s Disease
- Promising New Way to Detect Breast Cancer
- Moffitt Cancer Center Receives Prestigious SPORE Grant Worth More Than $10 Million
- Calif. Court Ruling On Physician Discrimination Based On Sexual Orientation Allows Equal Treatment, Editorial Says
- Linseed food to keep cancer at bay
